<bill session="114" type="h" number="4778" updated="2018-11-21T21:23:32Z">
  <state datetime="2016-03-17">REFERRED</state>
  <status>
    <introduced datetime="2016-03-17"/>
  </status>
  <introduced datetime="2016-03-17"/>
  <titles>
    <title type="short" as="introduced">Title X Transparency Act</title>
    <title type="official" as="introduced">To direct the Comptroller General to submit to Congress a report on medical items and services being offered in the facilities of recipients of assistance under title X of the Public Health Service Act (42 U.S.C. 300 et seq.) or of their affiliates, subsidiaries, successors, or clinics.</title>
    <title type="display">Title X Transparency Act</title>
  </titles>
  <sponsor bioguide_id="E000291"/>
  <cosponsors>
    <cosponsor bioguide_id="L000576" joined="2016-03-22"/>
  </cosponsors>
  <actions>
    <action datetime="2016-03-17">
      <text>Introduced in House</text>
    </action>
    <action datetime="2016-03-17" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2016-03-18">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Family planning and birth control"/>
    <term name="Government studies and investigations"/>
    <term name="Health facilities and institutions"/>
    <term name="Health programs administration and funding"/>
  </subjects>
  <amendments/>
  <summary date="2016-03-17T04:00:00Z" status="Introduced in House">Title X Transparency Act

This bill requires the Government Accountability Office to evaluate the medical items and services offered by recipients of federal family planning assistance or their affiliates, subsidiaries, successors, or clinics.</summary>
  <committee-reports/>
</bill>
